Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹14,278 Cr₹12,207 Cr₹10,260 Cr₹8,749 Cr₹7,782 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹14,278 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹14,278 Cr
Mar2025₹12,207 Cr
Mar2024₹10,260 Cr
Mar2023₹8,749 Cr
Mar2022₹7,782 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹14,278 Cr
16.96
Mar2025 ₹12,207 Cr
18.98
Mar2024 ₹10,260 Cr
17.27
Mar2023 ₹8,749 Cr
12.44
Mar2022 ₹7,782 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,572.7 Cr 9.1% 0.3% 2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,803.0 Cr 0.2% -5.2% 4.1% Stock Analytics
DIVIS LABORATORIES ₹253,833.0 Cr 4.9% -0.5% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,461.0 Cr -1.1% -8.5% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,463.0 Cr 7.8% 11% 1.2% Stock Analytics
CIPLA ₹109,870.0 Cr 2.3% -2.7% -18.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

9.1%

0.3%

2.2%

SENSEX

-0.6%

-0.5%

-13.2%


You may also like the below Video Courses